Doxazosin

Catalog No.S5782

Doxazosin Chemical Structure

Molecular Weight(MW): 451.48

Doxazosin is a quinazoline-derivative that selectively antagonizes postsynaptic α1-adrenergic receptors.

Size Price Stock Quantity  
USD 97 In stock
Bulk Discount

Free Overnight Delivery on orders over $ 500
Next day delivery by 10:00 a.m. Order now.

Purity & Quality Control

Choose Selective Adrenergic Receptor Inhibitors

Biological Activity

Description Doxazosin is a quinazoline-derivative that selectively antagonizes postsynaptic α1-adrenergic receptors.

Protocol

References

Solubility (25°C)

In vitro DMSO 31 mg/mL (68.66 mM)
Water Insoluble
Ethanol Insoluble

* Please note that Selleck tests the solubility of all compounds in-house, and the actual solubility may differ slightly from published values. This is normal and is due to slight batch-to-batch variations.

Chemical Information

Molecular Weight 451.48
Formula

C23H25N5O5

CAS No. 74191-85-8
Storage powder
in solvent
Synonyms N/A

Bio Calculators

Molarity Calculator

Molarity Calculator

Calculate the mass, volume or concentration required for a solution. The Selleck molarity calculator is based on the following equation:

Mass (mg) = Concentration (mM) × Volume (mL) × Molecular Weight (g/mol)

  • Mass
    Concentration
    Volume
    Molecular Weight

*When preparing stock solutions, please always use the batch-specific molecular weight of the product found on the via label and MSDS / COA (available on product pages).

Dilution Calculator

Dilution Calculator

Calculate the dilution required to prepare a stock solution. The Selleck dilution calculator is based on the following equation:

Concentration (start) x Volume (start) = Concentration (final) x Volume (final)

This equation is commonly abbreviated as: C1V1 = C2V2 ( Input Output )

  • C1
    V1
    C2
    V2

* When preparing stock solutions always use the batch-specific molecular weight of the product found on the vial label and MSDS / COA (available online).

The Serial Dilution Calculator Equation

  • Serial Dilutions

  • Computed Result

  • C1=C0/X C1: LOG(C1):
    C2=C1/X C2: LOG(C2):
    C3=C2/X C3: LOG(C3):
    C4=C3/X C4: LOG(C4):
    C5=C4/X C5: LOG(C5):
    C6=C5/X C6: LOG(C6):
    C7=C6/X C7: LOG(C7):
    C8=C7/X C8: LOG(C8):
Molecular Weight Calculator

Molecular Weight Calculator

Enter the chemical formula of a compound to calculate its molar mass and elemental composition:

Total Molecular Weight: g/mol

Tip: Chemical formula is case sensitive. C10H16N2O2 c10h16n2o2

Instructions to calculate molar mass (molecular weight) of a chemical compound:

To calculate molar mass of a chemical compound, please enter its chemical formula and click 'Calculate'.

Definitions of molecular mass, molecular weight, molar mass and molar weight:

Molecular mass (molecular weight) is the mass of one molecule of a substance and is expressed in the unified atomic mass units (u). (1 u is equal to 1/12 the mass of one atom of carbon-12)
Molar mass (molar weight) is the mass of one mole of a substance and is expressed in g/mol.

Molarity Calculator

Mass Concentration Volume Molecular Weight

Clinical Trial Information

NCT Number Recruitment interventions Conditions Sponsor/Collaborators Start Date Phases
NCT01946035 Completed Drug: Doxazosin XL|Other: Placebo Allergic Rhinitis University of Dundee September 2013 Phase 4
NCT01379898 Completed Drug: Phenoxybenzamine|Drug: Doxazosin Pheochromocytoma University Medical Center Groningen|Radboud University|UMC Utrecht|VU University of Amsterdam|Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)|Leiden University Medical Center|Erasmus Medical Center|Maastricht University Medical Center|St. Antonius Hospital|Medisch Spectrum Twente|Maxima Medical Center|Canisius-Wilhelmina Hospital|Onze Lieve Vrouwe Gasthuis|Atrium Medical Center|Isala December 2011 Phase 4
NCT01062945 Completed Drug: Placebo|Drug: Doxazosin Cocaine Addiction|Cocaine Abuse|Cocaine Dependence|Substance Abuse Baylor College of Medicine|National Institute on Drug Abuse (NIDA) January 2010 Phase 1
NCT00646841 Completed Drug: Doxazosin gastrointestinal therapeutic system (GITS) Hypertension Pfizer February 2003 Phase 4
NCT00645034 Completed Drug: placebo|Drug: sildenafil Benign Prostatic Hyperplasia Pfizer November 2002 Phase 2

Tech Support

Answers to questions you may have can be found in the inhibitor handling instructions. Topics include how to prepare stock solutions, how to store inhibitors, and issues that need special attention for cell-based assays and animal experiments.

Handling Instructions

Tel: +1-832-582-8158 Ext:3

If you have any other enquiries, please leave a message.

  • * Indicates a Required Field

Adrenergic Receptor Signaling Pathway Map

Related Adrenergic Receptor Products

Tags: buy Doxazosin | Doxazosin ic50 | Doxazosin price | Doxazosin cost | Doxazosin solubility dmso | Doxazosin purchase | Doxazosin manufacturer | Doxazosin research buy | Doxazosin order | Doxazosin mouse | Doxazosin chemical structure | Doxazosin mw | Doxazosin molecular weight | Doxazosin datasheet | Doxazosin supplier | Doxazosin in vitro | Doxazosin cell line | Doxazosin concentration | Doxazosin nmr
×
Cell Lines Assay Type Concentration Incubation Time Formulation Activity Description PMID